255 related articles for article (PubMed ID: 10740989)
1. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
Kapur S; Seeman P
J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
3. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
Lidow MS; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
[TBL] [Abstract][Full Text] [Related]
5. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor.
Sahlholm K; Zeberg H; Nilsson J; Ögren SO; Fuxe K; Århem P
Eur Neuropsychopharmacol; 2016 Mar; 26(3):467-76. PubMed ID: 26811292
[TBL] [Abstract][Full Text] [Related]
6. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer.
Barth VN; Chernet E; Martin LJ; Need AB; Rash KS; Morin M; Phebus LA
Life Sci; 2006 May; 78(26):3007-12. PubMed ID: 16434058
[TBL] [Abstract][Full Text] [Related]
8. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
Malmberg A; Jackson DM; Eriksson A; Mohell N
Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
10. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
Seeman P; Corbett R; Van Tol HH
Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
[TBL] [Abstract][Full Text] [Related]
11. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
Maheux J; Ethier I; Rouillard C; Lévesque D
J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic receptor-blocking concentrations of neuroleptics.
Seeman P
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():5-13. PubMed ID: 8866760
[TBL] [Abstract][Full Text] [Related]
13. Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs.
Ma J; Ye N; Cohen BM
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):647-57. PubMed ID: 16487641
[TBL] [Abstract][Full Text] [Related]
14. The importance of serotonin-dopamine interactions in the action of clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
16. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A
Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947
[TBL] [Abstract][Full Text] [Related]
17. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
Hjerde E; Dahl SG; Sylte I
Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653
[TBL] [Abstract][Full Text] [Related]
18. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
19. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
Rauser L; Savage JE; Meltzer HY; Roth BL
J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y
Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
